TY - JOUR
T1 - Countermeasures-based Improvements in Stress, Immune System Dysregulation and Latent Herpesvirus Reactivation onboard the International Space Station – Relevance for Deep Space Missions and Terrestrial Medicine
AU - Crucian, Brian E.
AU - Makedonas, George
AU - Sams, Clarence F.
AU - Pierson, Duane L.
AU - Simpson, Richard
AU - Stowe, Raymond P.
AU - Smith, Scott M.
AU - Zwart, Sara R.
AU - Krieger, Stephanie S.
AU - Rooney, Bridgette
AU - Douglas, Grace
AU - Downs, Meghan
AU - Nelman-Gonzalez, Mayra
AU - Williams, Thomas J.
AU - Mehta, Satish
N1 - Funding Information:
The authors thank the International Space Station crewmembers for participating in this study. The authors also acknowledge the support provided by the JSC Clinical Laboratory , the JSC Mission Integration Team , and the Kennedy Space Center Baseline Data Collection Facility during this study. The authors are particularly grateful for operational support provided by Mimi Shao at the Kennedy Space Center and Matt Roper, Marilyn Johnson and Karen Lawrence at the Johnson Space Center.
Publisher Copyright:
© 2020
PY - 2020/8
Y1 - 2020/8
N2 - The International Space Station (ISS) has continued to evolve from an operational perspective and multiple studies have monitored both stress and the immune system of ISS astronauts. Alterations were ascribed to a potentially synergistic array of factors, including microgravity, radiation, psychological stress, and circadian misalignment. Comparing similar data across 12 years of ISS construction and operations, we report that immunity, stress, and the reactivation of latent herpesviruses have all improved in ISS astronauts. Major physiological improvements seem to have initiated approximately 2012, a period coinciding with improvements onboard ISS including cargo delivery and resupply frequency, personal communication, exercise equipment and protocols, food quality and variety, nutritional supplementation, and schedule management. We conclude that spaceflight associated immune dysregulation has been positively influenced by operational improvements and biomedical countermeasures onboard ISS. Although an operational challenge, agencies should therefore incorporate, within vehicle design limitations, these dietary, operational, and stress-relieving countermeasures into deep space mission planning. Specific countermeasures that have benefited astronauts could serve as a therapy augment for terrestrial acquired immunodeficiency patients.
AB - The International Space Station (ISS) has continued to evolve from an operational perspective and multiple studies have monitored both stress and the immune system of ISS astronauts. Alterations were ascribed to a potentially synergistic array of factors, including microgravity, radiation, psychological stress, and circadian misalignment. Comparing similar data across 12 years of ISS construction and operations, we report that immunity, stress, and the reactivation of latent herpesviruses have all improved in ISS astronauts. Major physiological improvements seem to have initiated approximately 2012, a period coinciding with improvements onboard ISS including cargo delivery and resupply frequency, personal communication, exercise equipment and protocols, food quality and variety, nutritional supplementation, and schedule management. We conclude that spaceflight associated immune dysregulation has been positively influenced by operational improvements and biomedical countermeasures onboard ISS. Although an operational challenge, agencies should therefore incorporate, within vehicle design limitations, these dietary, operational, and stress-relieving countermeasures into deep space mission planning. Specific countermeasures that have benefited astronauts could serve as a therapy augment for terrestrial acquired immunodeficiency patients.
KW - Stress
KW - confinement
KW - exercise
KW - gravity
KW - immunity
KW - spaceflight
KW - viral reactivation
UR - http://www.scopus.com/inward/record.url?scp=85085971184&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85085971184&partnerID=8YFLogxK
U2 - 10.1016/j.neubiorev.2020.05.007
DO - 10.1016/j.neubiorev.2020.05.007
M3 - Review article
C2 - 32464118
AN - SCOPUS:85085971184
SN - 0149-7634
VL - 115
SP - 68
EP - 76
JO - Neuroscience and Biobehavioral Reviews
JF - Neuroscience and Biobehavioral Reviews
ER -